ARC-8, NCT04104672: A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies |
|
|
| Recruiting | 1 | 195 | US | AB680, Zimberelimab, AB122, Nab-paclitaxel, Abraxane, Gemcitabine, Gemzar | Arcus Biosciences, Inc. | Advanced Pancreatic Cancer | 05/27 | 05/27 | | |